GWHP
Global WholeHealth Partners Corporation [GWHP] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
GWHP Stock Summary
In the News
Global WholeHealth Partners Corp. (OTC: GWHP), is Approved to Sell Through Walmart, Amazon, eBay and Shopify as Stated in the 8K Filing 08/03/2021; Global's Newly Designed Tests Are Now Ready for the Launch into the Retail Marketplace
Global WholeHealth Partners Corp. (OTC: GWHP) is Now Funded for Growth, Sales, and Expansion from EMC2 Funding.
Global WholeHealth Partners Corp. (OTC: GWHP) Has Been Approved to Sell Its Products Through Walmart and Amazon as Stated in the 8K Filing 08/03/2021; Global's Newly Designed Tests Are Now Ready for the Launch Into the Retail Marketplace
SAN CLEMENTE, CA, Oct. 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Global WholeHealth Partners Corp. (OTC:GWHP) is presenting 5 OTC (Over the Counter) products to be sold in the retail marketplace
Global WholeHealth Partners Corp (OTC: GWHP) Partners With Pan Probe Biotech and AvantGen to Develop the Newest COVID19 Antigen Test on the Market; 8k Filed on 09/21/2021
Global WholeHealth Partners Corp (GWHP) is confident in the new partnerships to produce the best COVID Antigen test on the market.
FDA Approves First COVID-19 Vaccine Which Can Be Distributed by Global WholeHealth Partners Corp (OTC: GWHP) as US Anticipates Considerable Uptick in Vaccination Rates, as Stated in 8K Filing 06/15/21
SAN CLEMENTE, CA, Aug. 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Global WholeHealth Partners Corp. (OTC: GWHP) is readying for sales due to the transition from Emergency Use Status to Full FDA Approval of Vaccine developed by Pfizer-BioNTech, as stated in 8K filing 06/15/21.
Global WholeHealth Partners Corp. (OTC:GWHP) Gains Approval in a Deal to Sell Through Ebay's $100 Billion Online Marketplace as Stated in 8K Filing 08/05/21
SAN CLEMENTE, CA, Aug. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Global WholeHealth Partners Corp. (OTC: GWHP), a multinational supplier of over 70+ FDA Approved Diagnostic Tests, announces approval in deal to sell through Ebay's $100 Billion Online Marketplace.
Global WholeHealth Partners Corp.'s (OTC: GWHP) Antibody IgG/IgM and Antigen Tests That They Offer Are Capable of Detecting the DELTA B.1.617.2, United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1) of COVID 19 SARS 2
SAN CLEMENTE, CA, July 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Global WholeHealth Partners Corp. (OTC: GWHP) offers one of the largest line of Covid-19 tests. Global WholeHealth Partners Corp (OTC: GWHP) states that the Antibody IgG/IgM and Antigen tests that they offer are capable of detecting all the current identified SARS-CoV-2 viruses. The strains identified in DELTA B.1.617.2, United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1) strain contains multiple mutations, most reflected in the S gene, which encodes the spike protein, Global understands the need to be ahead of the virus to conquer the virus.
Global WholeHealth Partners, Corp. (OTC: GWHP) Confirms They Offer Antibody and Antigen Test Kits That Detect Fast Spreading Mutated COVID-19 Strains, DELTA (B.1.617.2), (UK (B.1.1.7), S. Africa (B.
SAN CLEMENTE, CA, July 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Global WholeHealth Partners, Corp. (OTC: GWHP), a multinational supplier of over 70+ FDA approved tests and including Dengue, Ebola, Zika, TB and Malaria for international sales, also offers one of the largest lines of tests for CoViD19 SARS2, and is prepared to help in the fight against CoViD19 SARS2. With the pandemic still not under control in the United States, and new variants coming out, Global needed to make sure it kept up with the needs of the nation and the world.
Global WholeHealth Partners Corp (OTC:GWHP) Gives an Update on Salud Previa of Tijuana, MX; Salud Previa is Located at Av. Paseo del Rio 6672 N2 L204 3ra Etapa Rio, Tijuana, Baja California, www.SaludPrevia.com
SAN CLEMENTE, CA, July 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Global WholeHealth Partners Corp (OTC:GWHP) gives an update on Salud Previa of Tijuana, MX; Salud Previa is located at Av. Paseo del Río 6672 N2 L204 3ra Etapa Río, Tijuana, Baja California.
Global WholeHealth Partners Corp (OTC:GWHP) Ships Its First Shipment of Over 20,000 Tests to Salud Previa of Tijuana, MX; Salud Previa Has Indicated That It Plans on Purchasing More Than 500,000 Tests Over the Next 12 Months
San Clemente, CA, July 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Global WholeHealth Partners Corp. (OTC: GWHP) offers one of the largest lines of COVID 19 tests. Global WholeHealth Partners Corp (OTC: GWHP) states that the Antibody IgG/IgM tests that they offer are capable of detecting all the current identified SARS-CoV-2 viruses. The strains identified in the United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1) strain contain multiple mutations, most reflected in the S gene, which encodes the spike protein. Global understands the need to be ahead of the virus to conquer the virus.
Findit Features Members Global WholeHealth Partners, ClassWorx and OTC Tip Reporter Who Utilize Findit Marketing Campaigns To Improve Online Exposure
ATLANTA, GA / ACCESSWIRE / June 23, 2021 / Findit, Inc. (OTC PINK:FDIT) owner of Findit.com®, a full-service social networking platform that provides online marketing campaigns and tools for members to increase brand awareness through content creation and sharing, resulting in indexing in search engines is highlighting: Global WholeHealth Partners (OTC PINK:GWHP), ClassWorx™ (OTC PINK:CHNO) and OTC Tip Reporter. In today's release, Findit® will be highlighting three featured members that utilize Findit® marketing campaigns.
GWHP Financial details
GWHP Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
| Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | -0.07 | -0.08 | -0.07 | 0 | |
| Operating cash flow per share | 0 | -0.01 | -0.01 | -0.02 | 0 | |
| Free cash flow per share | 0 | -0.01 | -0.01 | -0.02 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | 0 | 0 | 0 | -0.02 | 0 | |
| Tangible book value per share | 0 | 0 | 0 | -0.02 | 0 | |
| Share holders equity per share | 0 | 0 | 0 | -0.02 | 0 | |
| Interest debt per share | 0 | 0 | 0.02 | 0.02 | 0 | |
| Market cap | 38.3M | 406.94M | 22.72M | 995.39K | 0 | |
| Enterprise value | 38.28M | 407.12M | 22.78M | 1.69M | 0 | |
| P/E ratio | -1.38K | -94.52 | -4.12 | -0.16 | 0 | |
| Price to sales ratio | 0 | 1.68K | 565.34 | 134.97 | 0 | |
| POCF ratio | -210.46K | -593.96 | -35.35 | -0.51 | 0 | |
| PFCF ratio | -210.46K | -593.96 | -35.16 | -0.51 | 0 | |
| P/B Ratio | 1.93K | -6.81K | -234.04 | -0.63 | 0 | |
| PTB ratio | 1.93K | -6.81K | -234.04 | -0.63 | 0 | |
| EV to sales | 0 | 1.68K | 566.74 | 228.82 | 0 | |
| Enterprise value over EBITDA | -1.24K | -95.44 | -2.82 | -0.4 | 0 | |
| EV to operating cash flow | -210.35K | -594.21 | -35.44 | -0.86 | 0 | |
| EV to free cash flow | -210.35K | -594.21 | -35.25 | -0.86 | 0 | |
| Earnings yield | 0 | -0.01 | -0.24 | -6.15 | 0 | |
| Free cash flow yield | 0 | 0 | -0.03 | -1.98 | 0 | |
| Debt to equity | 0 | -3.19 | -1.35 | -0.44 | 0 | |
| Debt to assets | 0 | 1.05 | 0.32 | 26.08 | 0 | |
| Net debt to EBITDA | 0.65 | -0.04 | -0.01 | -0.17 | 0 | |
| Current ratio | 199.18 | 0.75 | 0.79 | 0.01 | 0 | |
| Interest coverage | -186.77 | -214.01 | -3.71 | -4.32 | 0 | |
| Income quality | 0.01 | 0.16 | 0.07 | 0.38 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 15.91 | 73.26 | 366.19 | 0 | |
| Research and developement to revenue | 0 | 2.12 | 11.98 | 186.13 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0.01 | 0 | 0 | |
| Capex to revenue | 0 | 0 | -0.09 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | -3.28 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0.02 | 0.06 | 0.24 | 0 | |
| Graham number | 0.02 | 0.04 | 0.05 | 0.16 | 0 | |
| ROIC | -1.54 | -32.69 | -64.47 | 5.67 | 0 | |
| Return on tangible assets | -1.39 | -23.69 | -13.41 | -230.76 | 0 | |
| Graham Net | 0 | -195.46 | -0.01 | -0.02 | 0 | |
| Working capital | 19.82K | -59.74K | -104.53K | -1.58M | 0 | |
| Tangible asset value | 19.82K | -59.74K | -97.1K | -1.57M | 0 | |
| Net current asset value | 19.82K | -59.74K | -104.53K | -1.58M | 0 | |
| Invested capital | 0 | -3.19 | -1.35 | -0.44 | 0 | |
| Average receivables | 0 | -7.53B | -7.53B | 0 | 0 | |
| Average payables | 0 | 23.16K | 97.63K | 161.34K | 86.86K | |
| Average inventory | 0 | 76.07K | 90.91K | 14.84K | 0 | |
| Days sales outstanding | 0 | -22.76M | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 112.27 | 269.81 | 529.83 | 0 | |
| Days of inventory on hand | 0 | 368.78 | 53.77 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 707135510.24B | 0 | 0 | |
| Payables turnover | 0 | 3.25 | 1.35 | 0.69 | 0 | |
| Inventory turnover | 0 | 0.99 | 6.79 | 0 | 0 | |
| ROE | -1.4 | 72.08 | 56.85 | 3.9 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q1
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | 0 | 0 | 0 | 0 | 0 | |
| Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
| Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value | 0 | 0 | 0 | 0 | 0 | |
| P/E ratio | 0 | 0 | 0 | 0 | 0 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
| PTB ratio | 0 | 0 | 0 | 0 | 0 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
| Current ratio | 0 | 0 | 0 | 0 | 0 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0 | 0 | 0 | 0 | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
| Graham Net | 0 | 0 | 0 | 0 | 0 | |
| Working capital | 0 | 0 | 0 | 0 | 0 | |
| Tangible asset value | 0 | 0 | 0 | 0 | 0 | |
| Net current asset value | 0 | 0 | 0 | 0 | 0 | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 86.86K | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0 | 0 | 0 | 0 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
GWHP Frequently Asked Questions
What is Global WholeHealth Partners Corporation stock symbol ?
Global WholeHealth Partners Corporation is a US stock , located in San clemente of Ca and trading under the symbol GWHP
Is Global WholeHealth Partners Corporation stock public?
Yes, Global WholeHealth Partners Corporation is a publicly traded company.
Company Profile
- Volume Average 17.66K
- Market Capitalization 131
- CEO Mr. F. Rene Alvarez Jr.
- Headquarters San Clemente,CA,US
- IPO Date 2015-04-09
-
Website
https://gwhpcorp.com 
Global WholeHealth Partners Corporation develops and markets various in-vitro diagnostic test kits in the United States. The company offers rapid diagnostic tests, such as the CoVid-19 test, whole blood Ebola test, whole blood Zika test, whole blood rapid TB test, and various other tests for over-the-counter or consumer-use, as well as for point-of-care, which includes hospitals, physicians' offices, and medical clinics. It provides tests for various diseases, such as Ebola, zika, dengue, malaria, influenza, tuberculosis, coronaviruses, and other vector-borne diseases. Global WholeHealth Partners Corporation was incorporated in 2013 and is based in San Clemente, California.
